
    
      Obese children with Moderate to Severe Sleep Apnea will have baseline evaluation of markers
      of cardiometabolic risk and insulin resistance. Subjects will then use either the CPAP or
      BiPAP machine for 3 months and will return for another blood draw for measurement of the
      markers for cardiometabolic risk and insulin resistance.
    
  